Towards Identification of Genetic and Neural Predictors of Adolescent Depression
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Mclean Hospital
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Neurobiological Activity in Frontostriatal and Mesolimbic Regions
Study Overview
Brief Summary
This study aims to examine the relationship between mood and brain activity in adolescent girls in order to better understand the genetic and neural predictors of adolescent depression. The participants in this study will be healthy female adolescents aged 12-14 and their mothers. They will participate for a total of six months. Adolescent participants will have three study sessions at McLean Hospital, and during two of them, their mothers will also have assessments. Adolescent assessments will include interviews, questionnaires, computer tasks, and collection of a saliva sample for genetic analyses. Their second study visit will include an fMRI scan. Parent assessments will include an interview, questionnaires, and a computer task.
Study Design
- Study Type
- Observational
- Observational Model
- Other
- Time Perspective
- Cross Sectional
Eligibility Criteria
- Ages
- 12 Years to — (Child, Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Adult Cohort
- •A. MDD Mothers Cohort Inclusion Criteria:
- •Current or past Major Depressive Disorder
- •English as first language or English fluency
- •Biological daughter who meets inclusion/
Exclusion Criteria
- •for High Risk Female Adolescent
- •B. Healthy Control Mothers Cohort Inclusion Criteria:
- •No history of psychopathology
- •English as first language or English fluency
- •Biological daughter who meets inclusion/exclusion criteria for Healthy Female Adolescent
- •Adolescent Cohort
- •General Inclusion Criteria for Adolescent Cohorts:
- •Ages 12-14
- •English as first language or English fluency
- •Right handed
- •General Exclusion Criteria for Adolescent Cohorts:
- •Past or present diagnosis of Major Depressive Disorder
- •Past or present diagnosis of any anxiety disorder
- •Past or present diagnosis of Bipolar Disorder
- •Past or present diagnosis of ADHD
- •Presence of medical or neurological illness (head injury, loss of consciousness greater than 5 minutes, seizure)
- •Current use of psychotropic medication
- •Presence of any contraindication for MRI:
- •Cardiac pacemakers
- •Metal clips on blood vessels (also called stents)
- •Artificial heart valve, artificial arms, hands, legs, etc.
- •Brain stimulator devices
- •Implanted drug pumps
- •Ear or eye implants
- •Known metal fragments in eyes
- •Exposure to metal filings or shrapnel (sheet metal workers, welders, and others)
- •Other metallic surgical hardware in vital area
- •Certain tattoos with metallic ink
- •Certain IUDs containing metal
- •Certain transdermal (skin) patches such as:
- •NicoDerm (nicotine for tobacco dependence)
- •Transderm Scop (scopolamine for motion sickness)
- •Ortho Evra (birth control)
- •Positive urine pregnancy test
- •C. High Risk Female Adolescent Additional Inclusion Criterion:
- •Biological daughter of participant in the MDD Mothers cohort
- •D. Healthy Female Adolescent Additional Inclusion Criterion:
- •Biological daughter of participant in the Healthy Control Mothers cohort
Arms & Interventions
MDD Mothers
Adult women with a history of major depressive disorder (MDD) and a healthy adolescent daughter between the ages of 12-14
Healthy Control Mothers
Adult women with no history of psychopathology and an adolescent daughter between the ages of 12-14
High Risk Female Adolescents
Healthy female adolescents aged 12-14 with a mother in the MDD Mothers cohort
Healthy Female Adolescents
Healthy female adolescents aged 12-14 with a mother in the Healthy Control Mothers cohort.
Outcomes
Primary Outcomes
Neurobiological Activity in Frontostriatal and Mesolimbic Regions
Time Frame: Baseline
Depressive Symptoms
Time Frame: 6 months
Secondary Outcomes
No secondary outcomes reported
Investigators
Diego Pizzagalli
Director
Mclean Hospital